http://www.fpnotebook.com/
Human Papilloma Virus VaccineAka: Quadrivalent Human Papillomavirus Vaccine, HPV Vaccine, Gardasil
- Indications
- Prevention of Cervical Dysplasia
- Females routinely at age 12 and catch-up <26 years
- Mechanism
- Mixture of primary capsid proteins of 4 HPV types
- Two low risk HPV types (but cause most Genital Warts)
- HPV 6
- HPV 11
- Two high risk HPV types
- HPV 16
- HPV 18
- Contraindications
- Pregnancy
- Adverse Effects
- Local pain at injection site: 80%
- Local redness or swelling: 25%
- Fever
- Low grade in 10%
- Over 102 degrees in 1.4%
- Dosings
- Intramuscular injection
- Schedule: 0, 2, and 6 months
- Cost
- Three doses: $440 (covered by most U.S. insurance plans)
- References
- Goeser (2007) Am Fam Physician 76:573-4
Human Papilloma Virus Vaccine (C1512511)
|
|---|
| Definition (NCI) | A recombinant vaccine of different types of HPV proteins which are well-conserved within types with a significant inter-type variation. |
| Definition (HL7V3.0) | human papilloma virus vaccine |
| Concepts | Amino Acid, Peptide, or Protein (T116)
, Pharmacologic Substance (T121)
, Immunologic Factor (T129)
|
| English | HPV, HPV Vaccine, HPV Vaccines, Human Papilloma Virus Vaccine, Human Papilloma Virus Vaccines, Human papillomavirus vaccine, Human Papillomavirus Vaccines |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
|
|---|
| Concepts | Pharmacologic Substance (T121)
, Immunologic Factor (T129)
|
| English | Gardasil, Merck brand of HPV quadrivalent vaccine |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Navigation Tree